Dimitrios Hatzichristos completed his doctoral dissertation at the Sahlgrenska School of Medicine at the University of Gothenburg in Sweden in June 2018, titled “Addison’s disease and type 1 diabetes.” In 2012, he received his certification in Endocrinology and Diabetology from the Swedish National Board of Health and Welfare, and in 2010, he had obtained his certification in Internal Medicine. He holds a license to practice medicine in both Greece and Sweden. He studied medicine at the University of Patras under Professor Apostolos Vagenakis, from which he graduated in 2002.
Since 2014, he has served as Senior Consultant and Director of the Outpatient Endocrinology Clinic, Diabetes, and Metabolism Outpatient Clinic at Sahlgrenska University Hospital in Gothenburg, Sweden. He began his career as a rural physician in Pyrgos (2002–2004).
In terms of research, he has published several articles focusing primarily on the management of patients with primary adrenal insufficiency and type 1 diabetes, as well as patients with Cushing’s disease. He has published studies on new biomarkers for glucocorticoids and will soon publish a study on Fabry-Anderson disease. His articles include clinical and epidemiological studies that examine new diagnostic approaches and ways to optimize the care of patients with endocrine disorders.
In addition to his academic work, he has served as Scientific Secretary of the Swedish Society of Endocrinologists since 2023 and as a review editor for international scientific journals since 2020. He is an active member of the Endocrine Society and the European Society of Endocrinologists.
